𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prostate-specific antigen and androgen deprivation therapy

✍ Scribed by H. C. Ruckle; J. E. Oesterling

Book ID
104655078
Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
702 KB
Volume
11
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pretreatment prostate-specific antigen v
Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy
✍ David Palma; Scott Tyldesley; Tom Pickles; for the Prostate Cohort Outcomes Init πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 1 views

## Abstract ## BACKGROUND In men with prostate cancer, pretreatment prostate‐specific antigen (PSA) velocity (PSAV) has been demonstrated as a predictor of biochemical and survival outcomes in patients undergoing radical prostatectomy (RP). The utility of pretreatment PSAV in predicting outcomes a

Efficacy of androgen deprivation therapy
Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer : Association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect
✍ Robert W. Ross; Wanling Xie; Meredith M. Regan; Mark Pomerantz; Mari Nakabayashi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 193 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The purpose of this study was to compare predictive factors for the efficacy of androgen deprivation therapy (ADT) in men with hormone‐sensitive prostate cancer (HSPC) either with (M+) or without (Mβˆ’) metastases. ## METHODS A cohort of prostate cancer patients was ident